DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 48 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $602,000 | -11.5% | 190,000 | -5.0% | 0.04% | +5.4% |
| Q1 2017 | $680,000 | +136.1% | 200,000 | +100.0% | 0.04% | +117.6% |
| Q4 2016 | $288,000 | -2.0% | 100,000 | +100.0% | 0.02% | +54.5% |
| Q3 2016 | $294,000 | -87.8% | 50,000 | -65.7% | 0.01% | -85.5% |
| Q4 2014 | $2,403,000 | -27.4% | 145,919 | -43.9% | 0.08% | -40.2% |
| Q3 2014 | $3,310,000 | -4.1% | 260,000 | +69.9% | 0.13% | -14.2% |
| Q2 2014 | $3,453,000 | +137.3% | 152,994 | +197.0% | 0.15% | +80.5% |
| Q1 2014 | $1,455,000 | – | 51,510 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |